Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 66

1.

Fluorescence molecular imaging for identification of high-grade dysplasia in patients with head and neck cancer.

Fakurnejad S, van Keulen S, Nishio N, Engelen M, van den Berg NS, Lu G, Birkeland A, Baik F, Colevas AD, Rosenthal EL, Martin BA.

Oral Oncol. 2019 Aug 12;97:50-55. doi: 10.1016/j.oraloncology.2019.08.008. [Epub ahead of print]

2.

Window of opportunity trials in head and neck cancer.

Farlow JL, Birkeland AC, Swiecicki PL, Brenner JC, Spector ME.

J Cancer Metastasis Treat. 2019;5. pii: 18. doi: 10.20517/2394-4722.2018.100. Epub 2019 Mar 18.

3.

The Sentinel Margin: Intraoperative Ex Vivo Specimen Mapping Using Relative Fluorescence Intensity.

van Keulen S, Nishio N, Birkeland A, Fakurnejad S, Martin B, Forouzanfar T, Cunanan K, Colevas AD, S van den Berg N, Rosenthal E.

Clin Cancer Res. 2019 Aug 1;25(15):4656-4662. doi: 10.1158/1078-0432.CCR-19-0319. Epub 2019 May 29.

PMID:
31142505
4.

The molecular landscape of the University of Michigan laryngeal squamous cell carcinoma cell line panel.

Mann JE, Kulkarni A, Birkeland AC, Kafelghazal J, Eisenberg J, Jewell BM, Ludwig ML, Spector ME, Jiang H, Carey TE, Brenner JC.

Head Neck. 2019 Sep;41(9):3114-3124. doi: 10.1002/hed.25803. Epub 2019 May 15.

PMID:
31090975
5.

Surgical margins in oral cavity squamous cell carcinoma: Current practices and future directions.

Kain JJ, Birkeland AC, Udayakumar N, Morlandt AB, Stevens TM, Carroll WR, Rosenthal EL, Warram JM.

Laryngoscope. 2019 Apr 26. doi: 10.1002/lary.27943. [Epub ahead of print] Review.

PMID:
31025711
6.

Elective Paratracheal Lymph Node Dissection in Salvage Laryngectomy.

Farlow JL, Birkeland AC, Rosko AJ, VanKoevering K, Haring CT, Smith JD, Brenner JC, Shuman AG, Chinn SB, Stucken CL, Malloy KM, Moyer JS, Casper KA, McLean SA, Prince MEP, Bradford CR, Wolf GT, Chepeha DB, Spector ME.

Ann Surg Oncol. 2019 Aug;26(8):2542-2548. doi: 10.1245/s10434-019-07270-6. Epub 2019 Mar 4.

PMID:
30830535
7.

Intraoperative Fluorescent Angiography Predicts Pharyngocutaneous Fistula After Salvage Laryngectomy.

Hoesli R, Brennan JR, Rosko AJ, Birkeland AC, Malloy KM, Moyer JS, Prince MEP, Shuman AG, Chinn SB, Stucken CL, Casper KA, Spector ME.

Ann Surg Oncol. 2019 May;26(5):1320-1325. doi: 10.1245/s10434-019-07262-6. Epub 2019 Feb 25.

PMID:
30805812
8.

The Clinical Application of Fluorescence-Guided Surgery in Head and Neck Cancer.

van Keulen S, Nishio N, Fakurnejad S, Birkeland A, Martin BA, Lu G, Zhou Q, Chirita SU, Forouzanfar T, Colevas AD, van den Berg NS, Rosenthal EL.

J Nucl Med. 2019 Jun;60(6):758-763. doi: 10.2967/jnumed.118.222810. Epub 2019 Feb 7.

9.

Rapid, non-invasive fluorescence margin assessment: Optical specimen mapping in oral squamous cell carcinoma.

van Keulen S, van den Berg NS, Nishio N, Birkeland A, Zhou Q, Lu G, Wang HW, Middendorf L, Forouzanfar T, Martin BA, Colevas AD, Rosenthal EL.

Oral Oncol. 2019 Jan;88:58-65. doi: 10.1016/j.oraloncology.2018.11.012. Epub 2018 Nov 21.

PMID:
30616798
10.

Mutational profiles of persistent/recurrent laryngeal squamous cell carcinoma.

Smith JD, Birkeland AC, Rosko AJ, Hoesli RC, Foltin SK, Swiecicki P, Mierzwa M, Chinn SB, Shuman AG, Malloy KM, Casper KA, McLean SA, Wolf GT, Bradford CR, Prince ME, Brenner JC, Spector ME.

Head Neck. 2019 Feb;41(2):423-428. doi: 10.1002/hed.25444. Epub 2018 Dec 12.

PMID:
30548484
11.

The genomic landscape of UM-SCC oral cavity squamous cell carcinoma cell lines.

Ludwig ML, Kulkarni A, Birkeland AC, Michmerhuizen NL, Foltin SK, Mann JE, Hoesli RC, Devenport SN, Jewell BM, Shuman AG, Spector ME, Carey TE, Jiang H, Brenner JC.

Oral Oncol. 2018 Dec;87:144-151. doi: 10.1016/j.oraloncology.2018.10.031. Epub 2018 Nov 8.

PMID:
30527230
12.

From VA Larynx to the future of chemoselection: Defining the role of induction chemotherapy in larynx cancer.

Spector ME, Rosko AJ, Swiecicki PL, Chad Brenner J, Birkeland AC.

Oral Oncol. 2018 Nov;86:200-205. doi: 10.1016/j.oraloncology.2018.09.026. Epub 2018 Oct 1. Review.

PMID:
30409302
13.

Analysis of tumor-infiltrating CD103 resident memory T-cell content in recurrent laryngeal squamous cell carcinoma.

Mann JE, Smith JD, Birkeland AC, Bellile E, Swiecicki P, Mierzwa M, Chinn SB, Shuman AG, Malloy KM, Casper KA, McLean SA, Moyer JS, Wolf GT, Bradford CR, Prince ME, Carey TE, McHugh JB, Spector ME, Brenner JC.

Cancer Immunol Immunother. 2019 Feb;68(2):213-220. doi: 10.1007/s00262-018-2256-3. Epub 2018 Oct 25.

PMID:
30361882
14.

Shoelaces: an interactive tool for ribosome profiling processing and visualization.

Birkeland Å, ChyŻyńska K, Valen E.

BMC Genomics. 2018 Jul 18;19(1):543. doi: 10.1186/s12864-018-4912-6.

15.

The potential for liquid biopsies in head and neck cancer.

Spector ME, Farlow JL, Haring CT, Brenner JC, Birkeland AC.

Discov Med. 2018 May;25(139):251-257. Review.

16.

Disorienting Dilemmas - the Significance of Resistance and Disturbance in an Intercultural Program within Kindergarten Teacher Education.

Birkeland Å, Ødemotland S.

Integr Psychol Behav Sci. 2018 Sep;52(3):377-387. doi: 10.1007/s12124-018-9433-y. Review.

PMID:
29779150
17.

Whole-Exome Sequencing of Sinonasal Small Cell Carcinoma Arising within a Papillary Schneiderian Carcinoma In Situ.

Smith J, Kulkarni A, Birkeland AC, McHugh JB, Brenner JC.

Otolaryngol Head Neck Surg. 2018 Nov;159(5):859-865. doi: 10.1177/0194599818774004. Epub 2018 May 8.

18.

First-line nurse managers' perceptions of the challenges involved in decision-making when older patients' wish to die.

Holm AL, Berland AK, Birkeland AK, Severinsson E.

Nurs Open. 2018 Feb 28;5(2):217-223. doi: 10.1002/nop2.131. eCollection 2018 Apr.

19.

A Pediatric Nasopharyngeal Mass.

Birkeland AC, McHugh JB, Bohm LA.

JAMA Otolaryngol Head Neck Surg. 2018 Apr 1;144(4):371-372. doi: 10.1001/jamaoto.2017.3072. No abstract available.

PMID:
29392294
20.

Proportion of CD4 and CD8 tumor infiltrating lymphocytes predicts survival in persistent/recurrent laryngeal squamous cell carcinoma.

Hoesli R, Birkeland AC, Rosko AJ, Issa M, Chow KL, Michmerhuizen NL, Mann JE, Chinn SB, Shuman AG, Prince ME, Wolf GT, Bradford CR, McHugh JB, Brenner JC, Spector ME.

Oral Oncol. 2018 Feb;77:83-89. doi: 10.1016/j.oraloncology.2017.12.003. Epub 2017 Dec 23.

21.

Hypothyroidism and Wound Healing After Salvage Laryngectomy.

Rosko AJ, Birkeland AC, Bellile E, Kovatch KJ, Miller AL, Jaffe CC, Shuman AG, Chinn SB, Stucken CL, Malloy KM, Moyer JS, Casper KA, Prince MEP, Bradford CR, Wolf GT, Chepeha DB, Spector ME.

Ann Surg Oncol. 2018 May;25(5):1288-1295. doi: 10.1245/s10434-017-6278-4. Epub 2017 Dec 20.

22.

Revisiting Expectations in an Era of Precision Oncology.

Marchiano EJ, Birkeland AC, Swiecicki PL, Spector-Bagdady K, Shuman AG.

Oncologist. 2018 Mar;23(3):386-388. doi: 10.1634/theoncologist.2017-0269. Epub 2017 Nov 20.

23.

Predictors of survival after total laryngectomy for recurrent/persistent laryngeal squamous cell carcinoma.

Birkeland AC, Beesley L, Bellile E, Rosko AJ, Hoesli R, Chinn SB, Shuman AG, Prince ME, Wolf GT, Bradford CR, Brenner JC, Spector ME.

Head Neck. 2017 Dec;39(12):2512-2518. doi: 10.1002/hed.24918. Epub 2017 Sep 30.

24.

Pathogenetic Analysis of Sinonasal Teratocarcinosarcomas Reveal Actionable β-catenin Overexpression and a β-catenin Mutation.

Birkeland AC, Burgin SJ, Yanik M, Scott MV, Bradford CR, McHugh JB, McLean SA, Sullivan SE, Nor JE, McKean EL, Brenner JC.

J Neurol Surg B Skull Base. 2017 Aug;78(4):346-352. doi: 10.1055/s-0037-1601320. Epub 2017 Mar 27.

25.

Preoperative Tracheostomy Is Associated with Poor Disease-Free Survival in Recurrent Laryngeal Cancer.

Birkeland AC, Rosko AJ, Beesley L, Bellile E, Chinn SB, Shuman AG, Prince ME, Wolf GT, Bradford CR, Brenner JC, Spector ME.

Otolaryngol Head Neck Surg. 2017 Sep;157(3):432-438. doi: 10.1177/0194599817709236. Epub 2017 Jun 6.

26.

Interdisciplinary collaboration in reablement - a qualitative study.

Birkeland A, Tuntland H, Førland O, Jakobsen FF, Langeland E.

J Multidiscip Healthc. 2017 May 5;10:195-203. doi: 10.2147/JMDH.S133417. eCollection 2017.

27.

Correlation of Crtc1/3-Maml2 fusion status, grade and survival in mucoepidermoid carcinoma.

Birkeland AC, Foltin SK, Michmerhuizen NL, Hoesli RC, Rosko AJ, Byrd S, Yanik M, Nor JE, Bradford CR, Prince ME, Carey TE, McHugh JB, Spector ME, Brenner JC.

Oral Oncol. 2017 May;68:5-8. doi: 10.1016/j.oraloncology.2017.02.025. Epub 2017 Mar 10.

28.

Immortal Life of the Common Rule: Ethics, Consent, and the Future of Cancer Research.

Smith JD, Birkeland AC, Goldman EB, Brenner JC, Carey TE, Spector-Bagdady K, Shuman AG.

J Clin Oncol. 2017 Jun 10;35(17):1879-1883. doi: 10.1200/JCO.2016.68.4522. Epub 2017 Apr 20. No abstract available. Erratum in: J Clin Oncol. 2017 Dec 20;35(36):4096.

29.

Survival and Margin Status in Head and Neck Radiation-Induced Sarcomas and De Novo Sarcomas.

Rosko AJ, Birkeland AC, Chinn SB, Shuman AG, Prince ME, Patel RM, McHugh JB, Spector ME.

Otolaryngol Head Neck Surg. 2017 Aug;157(2):252-259. doi: 10.1177/0194599817700389. Epub 2017 Apr 11.

PMID:
28397585
30.

Output-Sensitive Filtering of Streaming Volume Data.

Solteszova V, Birkeland Å, Stoppel S, Viola I, Bruckner S.

Comput Graph Forum. 2017 Jan;36(1):249-262. doi: 10.1111/cgf.12799. Epub 2016 Mar 1.

31.

Positron emission tomography-CT prediction of occult nodal metastasis in recurrent laryngeal cancer.

Rosko A, Birkeland A, Shuman A, Prince M, Bradford C, Wolf G, Worden F, Eisbruch A, Srinivasan A, Wong KK, Spector ME.

Head Neck. 2017 May;39(5):980-987. doi: 10.1002/hed.24719. Epub 2017 Feb 25.

32.

Genomic sequencing and precision medicine in head and neck cancers.

Hoesli RC, Ludwig ML, Michmerhuizen NL, Rosko AJ, Spector ME, Brenner JC, Birkeland AC.

Eur J Surg Oncol. 2017 May;43(5):884-892. doi: 10.1016/j.ejso.2016.12.002. Epub 2016 Dec 15. Review.

33.

E6 and E7 Antibody Levels Are Potential Biomarkers of Recurrence in Patients with Advanced-Stage Human Papillomavirus-Positive Oropharyngeal Squamous Cell Carcinoma.

Spector ME, Sacco AG, Bellile E, Taylor JMG, Jones T, Sun K, Brown WC, Birkeland AC, Bradford CR, Wolf GT, Prince ME, Moyer JS, Malloy K, Swiecicki P, Eisbruch A, McHugh JB, Chepeha DB, Rozek L, Worden FP.

Clin Cancer Res. 2017 Jun 1;23(11):2723-2729. doi: 10.1158/1078-0432.CCR-16-1617. Epub 2016 Nov 21.

34.

Integrative Medicine in Head and Neck Cancer.

Matovina C, Birkeland AC, Zick S, Shuman AG.

Otolaryngol Head Neck Surg. 2017 Feb;156(2):228-237. doi: 10.1177/0194599816671885. Epub 2016 Oct 13. Review.

35.

A Young Man With Hypercalcemia.

Yousif J, Birkeland AC, Spector ME.

JAMA Otolaryngol Head Neck Surg. 2017 Mar 1;143(3):311-312. doi: 10.1001/jamaoto.2016.2737. No abstract available.

36.

Genetic determinants in head and neck squamous cell carcinoma and their influence on global personalized medicine.

Michmerhuizen NL, Birkeland AC, Bradford CR, Brenner JC.

Genes Cancer. 2016 May;7(5-6):182-200. doi: 10.18632/genesandcancer.110.

37.

Maxilla Osteonecrosis: a differential diagnosis in patients with metastatic cancer on bisphosphonates.

Smith J, Birkeland AC, McHugh JB, Spector ME.

J Case Rep Med. 2016;5. pii: 235969. Epub 2016 Mar 10.

38.

Changing the paradigm: the potential for targeted therapy in laryngeal squamous cell carcinoma.

Ludwig ML, Birkeland AC, Hoesli R, Swiecicki P, Spector ME, Brenner JC.

Cancer Biol Med. 2016 Mar;13(1):87-100. doi: 10.28092/j.issn.2095-3941.2016.0010.

39.

Identification of Targetable ERBB2 Aberrations in Head and Neck Squamous Cell Carcinoma.

Birkeland AC, Yanik M, Tillman BN, Scott MV, Foltin SK, Mann JE, Michmerhuizen NL, Ludwig ML, Sandelski MM, Komarck CM, Carey TE, Prince ME, Bradford CR, McHugh JB, Spector ME, Brenner JC.

JAMA Otolaryngol Head Neck Surg. 2016 Jun 1;142(6):559-67. doi: 10.1001/jamaoto.2016.0335.

40.

Tumor Biomarkers in Spindle Cell Variant Squamous Cell Carcinoma of the Head and Neck.

Rosko AJ, Birkeland AC, Wilson KF, Muenz DG, Bellile E, Bradford CR, McHugh JB, Spector ME.

Otolaryngol Head Neck Surg. 2016 Jul;155(1):106-12. doi: 10.1177/0194599816636612. Epub 2016 Mar 15.

41.
42.

Prevalence and Outcomes of Head and Neck versus Non-Head and Neck Second Primary Malignancies in Head and Neck Squamous Cell Carcinoma: An Analysis of the Surveillance, Epidemiology, and End Results Database.

Birkeland AC, Rosko AJ, Chinn SB, Prince ME, Sun GH, Spector ME.

ORL J Otorhinolaryngol Relat Spec. 2016;78(2):61-9. doi: 10.1159/000443768. Epub 2016 Feb 25.

43.

The potential for tumor suppressor gene therapy in head and neck cancer.

Birkeland AC, Ludwig ML, Spector ME, Brenner JC.

Discov Med. 2016 Jan;21(113):41-7. Review.

44.

Occult Nodal Disease Prevalence and Distribution in Recurrent Laryngeal Cancer Requiring Salvage Laryngectomy.

Birkeland AC, Rosko AJ, Issa MR, Shuman AG, Prince ME, Wolf GT, Bradford CR, McHugh JB, Brenner JC, Spector ME.

Otolaryngol Head Neck Surg. 2016 Mar;154(3):473-9. doi: 10.1177/0194599815627811. Epub 2016 Feb 16.

45.

Fibroblast growth factor family aberrations as a putative driver of head and neck squamous cell carcinoma in an epidemiologically low-risk patient as defined by targeted sequencing.

Tillman BN, Yanik M, Birkeland AC, Liu CJ, Hovelson DH, Cani AK, Palanisamy N, Carskadon S, Carey TE, Bradford CR, Tomlins SA, McHugh JB, Spector ME, Brenner JCh.

Head Neck. 2016 Apr;38 Suppl 1:E1646-52. doi: 10.1002/hed.24292. Epub 2016 Feb 5.

46.

A review of drugs in development for the personalized treatment of head and neck squamous cell carcinoma.

Birkeland AC, Swiecicki PL, Brenner JC, Shuman AG.

Expert Rev Precis Med Drug Dev. 2016;1(4):379-385. doi: 10.1080/23808993.2016.1208050. Epub 2016 Jul 15.

47.

The Tip of the Iceberg: Clinical Implications of Genomic Sequencing Projects in Head and Neck Cancer.

Birkeland AC, Ludwig ML, Meraj TS, Brenner JC, Prince ME.

Cancers (Basel). 2015 Oct 21;7(4):2094-109. doi: 10.3390/cancers7040879. Review.

48.

Perceptually Uniform Motion Space.

Birkeland A, Turkay C, Viola I.

IEEE Trans Vis Comput Graph. 2014 Nov;20(11):1542-54. doi: 10.1109/TVCG.2014.2322363.

PMID:
26355333
49.

Targeting Head and Neck Cancer Stem Cells: Current Advances and Future Challenges.

Birkeland AC, Owen JH, Prince ME.

J Dent Res. 2015 Nov;94(11):1516-23. doi: 10.1177/0022034515601960. Epub 2015 Aug 25. Review. Erratum in: J Dent Res. 2017 Jul;96(8):957.

50.

Getting personal: Head and neck cancer management in the era of genomic medicine.

Birkeland AC, Uhlmann WR, Brenner JC, Shuman AG.

Head Neck. 2016 Apr;38 Suppl 1:E2250-8. doi: 10.1002/hed.24132. Epub 2015 Aug 13. Review.

Supplemental Content

Loading ...
Support Center